# Thymulin: The Zinc-Bound Thymic Nonapeptide, Read Through Its Neuroendocrine Axis

> Thymulin is a zinc-dependent thymic nonapeptide (pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn), active only when bound to one zinc ion. A sourced reference to its structure, mechanism, and the research record.

A literature reference to the sequence, the zinc-dependent mechanism, the thymus–pituitary signaling, and the precise point where the human data stop. Every quantitative claim is keyed to a study.

## The short version

Thymulin is a small hormone made by the thymus, the immune-training gland behind the breastbone. It is a nonapeptide — a chain of nine amino-acid building blocks — and it only switches on when one zinc atom is attached to it. Researchers have studied thymulin for how it helps T cells (the immune system's trained defender cells) mature, how it quiets inflammation, and how it talks to the brain's hormone-control center, the pituitary gland. Everything below is a digest of what published studies measured, in cells and in animals, with a little dated human data. Thymulin is a research peptide, not an FDA-approved drug, and this page does not give dosing advice.

## What is thymulin?

Thymulin is a zinc-dependent nonapeptide hormone produced exclusively by thymic epithelial cells — the thymus gland's lining cells that build the molecule. Its biological activity depends entirely on binding one zinc ion per peptide molecule in a 1:1 ratio; the zinc-free form is inactive [1][2]. The name *thymulin* was coined specifically for this zinc-bound active state. In its original literature the peptide was called serum thymic factor, or FTS (*facteur thymique sérique*), and the active complex is written FTS-Zn or Zn-thymulin [1].

Thymulin circulates from birth, peaks in childhood, and declines with age and with zinc deficiency [2][4]. Because its activity tracks zinc status so closely, serum thymulin has been used as a sensitive functional indicator of zinc availability rather than as a marketed compound [2][3]. It is a research peptide: not FDA-approved for any use, not a dietary supplement, and handled as a laboratory chemical.

Thymulin is frequently confused, in consumer writing, with other thymic peptides. It is chemically and pharmacologically distinct from thymosin alpha-1 and from thymosin beta-4, and from the bovine thymic complex thymalin — different molecules, with different research literatures [9]. The [thymulin vs thymosin alpha-1](/research) distinction is drawn out in full on the research page; this site keeps those lines clean and reads only the thymulin record.

## Thymulin Peptide: Structure and Identity

Thymulin (the *thymulin peptide*) is the linear nonapeptide pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn — written `<Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn`, with a pyroglutamate residue (a cyclized N-terminal cap) at the front [2]. Its molecular formula is C33H54N12O15, with a molecular weight near 858.86 Da and CAS number 63958-90-7. The bound zinc ion is part of what makes the active molecule: nuclear magnetic resonance work shows that zinc binding induces a specific three-dimensional conformation, and the apopeptide (the zinc-free chain) does not adopt it [2].

That conformational switch is the defining mechanistic fact of the molecule, and it is the subject of [why thymulin depends on zinc](/zinc-dependence). The structural identity also explains why thymulin is studied as a metallopeptide — a peptide whose function is inseparable from its bound metal — rather than as a peptide that merely happens to need a cofactor.

## What the research record covers

The thymulin literature runs along several parallel channels. The immune channel is the classical one: thymulin drives T-cell differentiation and modulates T-cell subset balance [2]. The anti-inflammatory channel is more recent: in lipopolysaccharide-challenged mice, thymulin lowered pro-inflammatory cytokines and modulated NF-kB (a master switch that turns inflammation genes on) and SAPK/JNK signaling [6]. The neuroendocrine channel is this site's editorial lens — thymulin acts as a hypophysiotropic peptide, signaling to the pituitary, and directly stimulated ACTH release from rat anterior pituitary cells in vitro, with a maximal effect near 10 pM [4][11].

A fourth, reproductive channel emerged from gene-therapy work: in congenitally athymic mice, an adenoviral vector expressing a synthetic thymulin analog preserved circulating gonadotropins and ovarian function [9][10]. These are research findings in their study species and models — described, not prescribed. Read them in full in the [thymulin research findings](/research), trace the signaling in [thymulin and the neuroendocrine axis](/neuroendocrine-axis), and see the study doses in [thymulin dosage in the literature](/dosage).

## What does thymulin do in the body?

Endogenously, thymulin is a thymic hormone: produced by thymic epithelial cells, it drives T-lymphocyte differentiation and helps set T-cell subset balance, and it participates in a bidirectional thymus–neuroendocrine loop [2][4]. In rat pituitary cells in vitro, zinc-bound thymulin directly stimulated ACTH release, evidence of a hypophysiotropic action [11]. Its own secretion is, in turn, regulated by the neuroendocrine system [4].

## Is thymulin produced naturally in the body?

Yes. Thymulin is produced exclusively by thymic epithelial cells. It circulates from birth, peaks in childhood, and declines with age and with zinc deficiency [2][4]. Because production is concentrated in thymic tissue and depends on zinc, serum thymulin activity falls as the thymus involutes with age and as zinc status drops [2][3].

## What is the amino acid sequence of thymulin?

Thymulin is the linear nonapeptide pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (`<Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn`), molecular formula C33H54N12O15, with a bound zinc ion required for activity [1][2]. The N-terminal pyroglutamate is a cyclized glutamine residue; the nine-residue chain is short even by peptide-hormone standards.

---

A typographic reference to the thymulin literature — the zinc-bound thymic nonapeptide set down sequence-first, its established findings ruled apart from its open human-data gaps and held distinct from thymosin alpha-1; a reading desk, not a clinic, a vendor, or a prescription.